Concepedia

Sahr Yazdani

SY

Statistics

Publications

4

Citations

304

H-Index

4

Active since

2018

Affiliations

University of Michigan(Current)

Howard Hughes Medical Institute

Michigan Medicine

Michigan Center for Translational Pathology

Children's Hospital of Philadelphia

Sahr Yazdani is an author at University of Michigan specializing in medicine, oncology, and tumor progression.

Publications per year

2018–2024

4

Publications

4

Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression

Yajia Zhang, Sethuramasundaram Pitchiaya, Marcin Cieślik et al. · Nature Genetics · 2018 · 238 citations

Medicine, Molecular Biology, Molecular Genetics +13

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor

Benjamin Lerman, Yimei Li, Cecilia Carlowicz et al. · Journal of Clinical Oncology · 2022 · 42 citations

Medicine, Oncology, Pharmacotherapy +13

Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma

Jae Eun Choi, Monique Verhaegen, Sahr Yazdani et al. · Neoplasia · 2019 · 13 citations · Full text

Medicine, Cell Biology, Oncology +16

PIKfyve, expressed by CD11c-positive cells, controls tumor immunity

Jae Eun Choi, Yuanyuan Qiao, Ilona Kryczek et al. · Nature Communications · 2024 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17

1–4 of 4